Menstrual Migraine

Neurology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
DiaryPhase 41 trial
Active Trials
NCT01578941Completed12Est. Sep 2012
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
auricular point detectionN/A1 trial
Active Trials
NCT03702114UnknownEst. Mar 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKDiary
City Therapeuticsauricular point detection

Clinical Trials (2)

Total enrollment: 12 patients across 2 trials

An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine

Start: Jan 2011Est. completion: Sep 201212 patients
Phase 4Completed
NCT03702114City Therapeuticsauricular point detection

Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )

Start: Oct 2018Est. completion: Mar 2019
N/AUnknown

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space